Patients with advanced lung cancer: is there scope to discontinue inappropriate medication?

Title
Patients with advanced lung cancer: is there scope to discontinue inappropriate medication?
Authors
Keywords
Erlotinib, Inappropriate medication, Limited life expectancy, Lung cancer, Medication review, Polypharmacy
Journal
International Journal of Clinical Pharmacy
Volume 35, Issue 2, Pages 181-184
Publisher
Springer Nature
Online
2012-12-10
DOI
10.1007/s11096-012-9731-2

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started